Chlamydia trachomatis Native Protein

• Reactivity: Ba
• Applications: ELISA
• Concentration: 4.9 mg/ml

Chlamydia trachomatis Native Protein Summary

• Description: Native Chlamydia trachomatis LGV type II strain 434 cultured in mouse L cells.
  
  

  Source:Chlamydia trachomatis

• Preparation Method: Mouse L cells are infected with C. trachomatis elementary bodies. Optimally infected cells are harvested and disrupted by sonication in phosphate bufffered saline. Cellular debris is removed by centrifugation. The antigen preparation is inactivated using gamma radiation, which primarily damages chlamydial genetic material.
• Protein/Peptide Type: Native Protein

Applications/Dilutions

• Dilutions:
  • ELISA
  • Immunoassay

Packaging, Storage & Formulations

• Storage: Store at -70C. Avoid freeze-thaw cycles.
• Buffer: PBS
• Preservative: No Preservative
• Concentration: 4.9 mg/ml

Alternate Names for Chlamydia trachomatis Native Protein

• C.trachomatis

Background

Chlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5% to 10%. Chlamydia is one of the leading causes of blindness in underdeveloped countries.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.